Kuroda Y - Search Results

1

Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.

Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, Suzuki K, Isoda A, Matsumoto M, Sawamura M, Sunami K, Takezako N, Hagiwara S, Kuroda Y, Chou T, Nagura E, Shimizu K. Ozaki S, et al. Among authors: kuroda y. Ann Hematol. 2019 Jul;98(7):1703-1711. doi: 10.1007/s00277-019-03702-1. Epub 2019 May 2. Ann Hematol. 2019. PMID: 31049648

2

Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cells.

Okikawa Y, Sakai A, Takimoto Y, Noda M, Imagawa J, Katayama Y, Kuroda Y, Okita H, Fujimura K, Kimura A. Okikawa Y, et al. Among authors: kuroda y. Int J Hematol. 2004 May;79(4):364-8. doi: 10.1532/ijh97.04005. Int J Hematol. 2004. PMID: 15218967

3

Connective tissue growth factor is an indicator of bone involvement in multiple myeloma, but matrix metalloproteinase-9 is not.

Munemasa S, Sakai A, Kuroda Y, Okikawa Y, Katayama Y, Asaoku H, Kubo T, Miyakawa Y, Serikawa M, Sasaki T, Kimura A. Munemasa S, et al. Among authors: kuroda y. Br J Haematol. 2007 Oct;139(1):41-50. doi: 10.1111/j.1365-2141.2007.06721.x. Br J Haematol. 2007. PMID: 17854305 Free article.

4

Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiation.

Munemasa S, Sakai A, Kuroda Y, Okikawa Y, Katayama Y, Asaoku H, Kubo T, Shimose S, Kimura A. Munemasa S, et al. Among authors: kuroda y. Int J Oncol. 2008 Jul;33(1):129-36. Int J Oncol. 2008. PMID: 18575758

5

Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.

Kuroda Y, Sakai A, Tsuyama N, Katayama Y, Munemasa S, Asaoku H, Okikawa Y, Nakaju N, Mizuno M, Ogawa K, Nishisaka T, Matsui H, Tanaka H, Kimura A. Kuroda Y, et al. Int J Oncol. 2008 Dec;33(6):1201-13. Int J Oncol. 2008. PMID: 19020753

6

Clinical significance of sIL-2R levels in B-cell lymphomas.

Yoshida N, Oda M, Kuroda Y, Katayama Y, Okikawa Y, Masunari T, Fujiwara M, Nishisaka T, Sasaki N, Sadahira Y, Mihara K, Asaoku H, Matsui H, Seto M, Kimura A, Arihiro K, Sakai A. Yoshida N, et al. Among authors: kuroda y. PLoS One. 2013 Nov 13;8(11):e78730. doi: 10.1371/journal.pone.0078730. eCollection 2013. PLoS One. 2013. PMID: 24236041 Free PMC article.

7

Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.

Harada T, Ozaki S, Oda A, Tsuji D, Ikegame A, Iwasa M, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Kuroda Y, Kawai S, Itoh K, Yamada-Okabe H, Matsumoto T, Abe M. Harada T, et al. Among authors: kuroda y. PLoS One. 2013 Dec 26;8(12):e83905. doi: 10.1371/journal.pone.0083905. eCollection 2013. PLoS One. 2013. PMID: 24386306 Free PMC article.

8

Vertebral fracture risk of multiple myeloma assessed by a CT-based finite element and trabecular structure analysis.

Takasu M, Kaichi Y, Awai K, Asaoku H, Kuroda Y, Sakai A. Takasu M, et al. Among authors: kuroda y. Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):12-3. doi: 10.1016/j.clml.2013.12.012. Epub 2013 Dec 24. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24461804 No abstract available.

9

Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.

Ozaki S, Harada T, Saitoh T, Shimazaki C, Itagaki M, Asaoku H, Kuroda Y, Chou T, Yoshiki Y, Suzuki K, Murakami H, Hayashi K, Mina R, Palumbo A, Shimizu K; Japanese Society of Myeloma; European Myeloma Network. Ozaki S, et al. Among authors: kuroda y. Acta Haematol. 2014;132(2):211-9. doi: 10.1159/000357394. Acta Haematol. 2014. PMID: 24662986 Free article.

10

Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.

Mu S, Kuroda Y, Shibayama H, Hino M, Tajima T, Corrado C, Lin R, Waldron E, Binlich F, Suzuki K. Mu S, et al. Among authors: kuroda y. Eur J Clin Pharmacol. 2016 Feb;72(2):153-61. doi: 10.1007/s00228-015-1967-z. Epub 2015 Oct 22. Eur J Clin Pharmacol. 2016. PMID: 26494130 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,005 results

Search Page